In particular, different lncRNAs have been found to be dysregulated in Alzheimer’s disease (e.g., BACE1-AS and NDM29) and to be involved in AD pathogenesis by promoting β-amyloid production. This evidence concerns the gene BACE1 and Alzheimer disease.